Blockbuster GLP-1 medications are changing patient care, impacting surgery volumes and reshaping the financial landscape of the healthcare industry.
Patients using GLP-1 drugs had no difference in the odds of postoperative aspiration pneumonia versus non-users. Preoperative ...
GLP-1 drugs on the market include Novo ... Updated ago Energycategory CERAWEEK Virginia governor say US must develop fusion or fall behind China on energy 1:59 AM UTC · Updated ago category ...
Biomea Fusion (BMEA) announced that it will feature two oral presentations, one poster presentation, and chair a symposium at the 18th ...
Presentation to highlight new clinical data from COVALENT-111, including c-peptide dataREDWOOD CITY, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical ...
Feb. 27, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq ... data evaluating the combination of icovamenib with GLP-1 receptor agonists, as well as new clinical findings ...
Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but preserve and even increase muscle and lean mass- Élancé Therapeutics ...